Gyre Therapeutics, Inc. Public Market Comparables
Find the most relevant public market comparables for Gyre Therapeutics, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
A commercial-stage biopharmaceutical company focused on the research, development, manufacturing, and commercialization of drugs for organ fibrosis. They develop and commercialize small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, specifically organ fibrosis. The company has commercial-stage products and a diverse pipeline of drug candidates, operating in both the US and China.
Business Model
Research, development, manufacturing, and commercialization of drugs for organ fibrosis.
Target Customers
Patients with organ fibrosis, including those with NASH-associated fibrosis, CHB-associated liver fibrosis, IPF, SSc-ILD, PF-ILD, CLD-associated thrombocytopenia, and chronic idiopathic thrombocytopenia.
Specific Focus
Organ fibrosis treatment
Location
San Diego, California
CEO
Han Ying, Ph.D.
Industry
Life sciences
Sub Sector
Biotechnology
3yr Revenue Growth
442%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Gyre Therapeutics, Inc. in the Pharmaceuticals & Biotech sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Gyre Therapeutics, Inc.? Our platform provides detailed analysis of Gyre Therapeutics, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Gyre Therapeutics, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Gyre Therapeutics, Inc. Compset
As a leading player in the Life sciences industry within the Pharmaceuticals & Biotech sector, Gyre Therapeutics, Inc. operates in the specialized Biotechnology sub-sector. Understanding how Gyre Therapeutics, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Transmedics Group, Inc.
Medical Technology • Life sciences
TransMedics Group, Inc. is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. They developed the Organ Care System (OCS) to replace a decades-old standard of care, aiming to significantly increase access to life-saving transplant therapy. The OCS replicates many aspects of an organ's natural living and functioning environment outside the human body.
Intra-Cellular Therapies, Inc.
Pharmaceuticals • Life sciences
A biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders. The company develops novel drugs for treating diseases of the central nervous system, leveraging proprietary chemistry platforms to develop drugs for neurodegenerative diseases.
BioCryst Pharmaceuticals Inc.
Biotechnology • Life sciences
BioCryst Pharmaceuticals Inc. is a biotechnology company that designs, optimizes, and develops small molecule drugs to block critical enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary angioedema.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Gyre Therapeutics, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free